Sato Pharmaceuticals Co., Ltd.

1 FDA products 1 active ingredients HUMAN OTC DRUG

Sato Pharmaceuticals Co., Ltd. is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human otc drug products.

About Sato Pharmaceuticals Co., Ltd.

Sato Pharmaceuticals Co., Ltd. is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by CAMPHOR, CAPSAICIN, MENTHOL. Most of these labels are human otc drug products. Labelling across this portfolio most often references: temporary relief, minor aches, pains muscles, joints due, simple backache, arthritis strains, bruises sprains. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
CAMPHOR, CAPSAICIN, MENTHOL 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — TOPICAL 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Sato Pharmaceuticals Co., Ltd.

Brand nameGenericTypeRoute
SATOHAP COOL and HOT CAMPHOR, CAPSAICIN, MENTHOL HUMAN OTC DRUG TOPICAL

Frequently asked questions

How many FDA drug products does Sato Pharmaceuticals Co., Ltd. make?
1 FDA drug label records name Sato Pharmaceuticals Co., Ltd. as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does Sato Pharmaceuticals Co., Ltd. produce?
The most frequent active ingredients in this portfolio are CAMPHOR, CAPSAICIN, MENTHOL.

Are Sato Pharmaceuticals Co., Ltd. products prescription or over-the-counter?
The largest share of this company’s labels are human otc drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.